Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Novel molecular targets of dezocine and their clinical implications.

Liu R, Huang XP, Yeliseev A, Xi J, Roth BL.

Anesthesiology. 2014 Mar;120(3):714-23. doi: 10.1097/ALN.0000000000000076.

3.

Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.

Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.

J Med Chem. 1998 Jul 16;41(15):2872-81.

PMID:
9667975
4.

Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.

Agirregoitia E, Valdivia A, Carracedo A, Casis L, Gil J, Subiran N, Ochoa C, Irazusta J.

J Clin Endocrinol Metab. 2006 Dec;91(12):4969-75. Epub 2006 Sep 19.

PMID:
16984994
5.

Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.

Seki T, Awamura S, Kimura C, Ide S, Sakano K, Minami M, Nagase H, Satoh M.

Eur J Pharmacol. 1999 Jul 2;376(1-2):159-67.

PMID:
10440101
6.

The presence of delta and mu-, but not kappa or ORL(1) receptors in bovine pinealocytes.

Govitrapong P, Sawlom S, Ebadi M.

Brain Res. 2002 Sep 27;951(1):23-30.

PMID:
12231452
7.

The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine.

Chen JC, Smith ER, Cahill M, Cohen R, Fishman JB.

Life Sci. 1993;52(4):389-96.

PMID:
8093631
8.

The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes.

Govitrapong P, Sawlom S, Chetsawang B, Sangchot P, Ebadi M.

Proc West Pharmacol Soc. 2002;45:32-5. No abstract available.

PMID:
12434519
9.

Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.

Ananthan S, Khare NK, Saini SK, Davis P, Dersch CM, Porreca F, Rothman RB.

Bioorg Med Chem. 2003 Sep 1;11(18):4143-54.

PMID:
12927876
10.

L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.

Sbrenna S, Marti M, Morari M, Calo G, Guerrini R, Beani L, Bianchi C.

J Pharmacol Exp Ther. 1999 Dec;291(3):1365-71.

11.

Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.

Munro TA, Huang XP, Inglese C, Perrone MG, Van't Veer A, Carroll FI, Béguin C, Carlezon WA Jr, Colabufo NA, Cohen BM, Roth BL.

PLoS One. 2013 Aug 14;8(8):e70701. doi: 10.1371/journal.pone.0070701. eCollection 2013.

12.

Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).

Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA.

Psychopharmacology (Berl). 2008 Jun;198(2):271-8. doi: 10.1007/s00213-008-1130-y. Epub 2008 Apr 8.

PMID:
18392754
13.

Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.

Zaveri NT, Journigan VB, Polgar WE.

ACS Chem Neurosci. 2015 Apr 15;6(4):646-57. doi: 10.1021/cn500367b. Epub 2015 Feb 18.

14.
16.

General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.

Miner P, Shimonova L, Khaimov A, Borukhova Y, Ilyayeva E, Ranaldi R, Bodnar RJ.

Brain Res. 2012 Mar 14;1443:34-51. doi: 10.1016/j.brainres.2012.01.015. Epub 2012 Jan 17.

PMID:
22305145
17.

BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.

Husbands SM, Neilan CL, Broadbear J, Grundt P, Breeden S, Aceto MD, Woods JH, Lewis JW, Traynor JR.

Eur J Pharmacol. 2005 Feb 21;509(2-3):117-25.

PMID:
15733546
18.

Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding.

Feigenbaum JJ, Simantov R.

Neurosci Lett. 1996 Jul 5;212(1):5-8.

PMID:
8823749
19.

Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.

Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubié M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL.

J Neurosci. 1998 Sep 15;18(18):7285-95.

20.

Supplemental Content

Support Center